Syncom Formulations (India) Limited (BOM:524470)
India
· Delayed Price · Currency is INR 21.50
-0.35 (-1.60%)
At close: Jun 13, 2025
BOM:524470 Revenue
In the fiscal year ending March 31, 2025, Syncom Formulations (India) had annual revenue of 4.65B INR with 76.55% growth. Syncom Formulations (India) had revenue of 1.49B in the quarter ending March 31, 2025, with 99.64% growth.
Revenue
4.65B
Revenue Growth
+76.55%
P/S Ratio
4.35
Revenue / Employee
4.66M
Employees
998
Market Cap
20.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.65B | 2.02B | 76.55% |
| Mar 31, 2024 | 2.63B | 391.33M | 17.45% |
| Mar 31, 2023 | 2.24B | 45.91M | 2.09% |
| Mar 31, 2022 | 2.20B | -251.42M | -10.27% |
| Mar 31, 2021 | 2.45B | 392.94M | 19.12% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |